Pim1 Protein

<strong>Pim1 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2019351_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5  µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 62 kDa_x000D_ <strong>Supplied as:</strong> Resin_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −70°C_x000D_ <strong>Keywords:</strong> Pim1 Protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Fisch D, Pfleiderer MM, Anastasakou E, Mackie GM, Wendt F, Liu X, Clough B, Lara-Reyna S, Encheva V, Snijders AP, Bando H, Yamamoto M, Beggs AD, Mercer J, Shenoy AR, Wollscheid B, Maslowski KM, Galej WP, Frickel EM. PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection Science. 2023 Oct 6;382(6666):eadg2253._x000D_ 2: Li H, Xie L, Zhu L, Li Z, Wang R, Liu X, Huang Z, Chen B, Gao Y, Wei L, He C, Ju R, Liu Y, Liu X, Zheng Y, Su W. Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis Nat Commun. 2022 Oct 4;13(1):5866._x000D_ 3: Ebeid DE, Firouzi F, Esquer CY, Navarrete JM, Wang BJ, Gude NA, Sussman MA. PIM1 Promotes Survival of Cardiomyocytes by Upregulating c-Kit Protein Expression Cells. 2020 Aug 31;9(9):2001._x000D_ 4: Zhang F, Beharry ZM, Harris TE, Lilly MB, Smith CD, Mahajan S, Kraft AS. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells Cancer Biol Ther. 2009 May;8(9):846-53._x000D_ 5: Zhao W, Qiu R, Li P, Yang J. PIM1: a promising target in patients with triple-negative breast cancer Med Oncol. 2017 Aug;34(8):142._x000D_ 6: Yang X, Liu C, Lei Y, Liu Z, Zhu B, Zhao D. PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target Front Immunol. 2024 Sep 20;15:1443784._x000D_ 7: Mahata S, Sahoo PK, Pal R, Sarkar S, Mistry T, Ghosh S, Nasare VD. PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer Med Oncol. 2022 May 15;39(5):74._x000D_ 8: Dutta A, Nath D, Yang Y, Le BT, Rahman MF, Faughnan P, Wang Z, Stuver M, He R, Tan W, Hutchison RE, Foulks JM, Warner SL, Zang C, Mohi G. Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models Leukemia. 2022 Mar;36(3):746-759._x000D_ 9: Magnuson NS, Wang Z, Ding G, Reeves R. Why target PIM1 for cancer diagnosis and treatment? Future Oncol. 2010 Sep;6(9):1461-78._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/39487435">10: Choudhury R, Bahadi CK, Ray IP, Dash P, Pattanaik I, Mishra S, Mohapatra SR, Patnaik S, Nikhil K. PIM1 kinase and its diverse substrate in solid tumors Cell Commun Signal. 2024 Nov 1;22(1):529. </a>_x000D_ _x000D_ <strong>Products Related to Pim1 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>